ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer
- PMID: 9463314
- PMCID: PMC1376883
- DOI: 10.1086/301706
ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer
Abstract
We report the spectrum of 59 ATM mutations observed in ataxia-telangiectasia (A-T) patients in the British Isles. Of 51 ATM mutations identified in families native to the British Isles, 11 were founder mutations, and 2 of these 11 conferred a milder clinical phenotype with respect to both cerebellar degeneration and cellular features. We report, in two A-T families, an ATM mutation (7271T-->G) that may be associated with an increased risk of breast cancer in both homozygotes and heterozygotes (relative risk 12.7; P=. 0025), although there is a less severe A-T phenotype in terms of the degree of cerebellar degeneration. This mutation (7271T-->G) also allows expression of full-length ATM protein at a level comparable with that in unaffected individuals. In addition, we have studied 18 A-T patients, in 15 families, who developed leukemia, lymphoma, preleukemic T-cell proliferation, or Hodgkin lymphoma, mostly in childhood. A wide variety of ATM mutation types, including missense mutations and in-frame deletions, were seen in these patients. We also show that 25% of all A-T patients carried in-frame deletions or missense mutations, many of which were also associated with expression of mutant ATM protein.
Similar articles
-
Ataxia telangiectasia gene mutations in leukaemia and lymphoma.J Clin Pathol. 2001 Jul;54(7):512-6. doi: 10.1136/jcp.54.7.512. J Clin Pathol. 2001. PMID: 11429421 Free PMC article. Review.
-
Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T-->G mutations, showing a less severe phenotype.J Biol Chem. 2001 Aug 10;276(32):30133-41. doi: 10.1074/jbc.M103160200. Epub 2001 May 29. J Biol Chem. 2001. PMID: 11382771
-
Ataxia-telangiectasia, cancer and the pathobiology of the ATM gene.Clin Genet. 1999 May;55(5):289-304. doi: 10.1034/j.1399-0004.1999.550501.x. Clin Genet. 1999. PMID: 10422797 Review.
-
Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours.Br J Cancer. 2011 Aug 9;105(4):586-91. doi: 10.1038/bjc.2011.266. Epub 2011 Jul 26. Br J Cancer. 2011. PMID: 21792198 Free PMC article.
-
ATM mutations in cancer families.Cancer Res. 1996 Sep 15;56(18):4130-3. Cancer Res. 1996. PMID: 8797579
Cited by
-
The Breast Cancer Tumor Suppressor TRIM29 Is Expressed via ATM-dependent Signaling in Response to Hypoxia.J Biol Chem. 2016 Oct 7;291(41):21541-21552. doi: 10.1074/jbc.M116.730960. Epub 2016 Aug 17. J Biol Chem. 2016. PMID: 27535224 Free PMC article.
-
First international workshop of the ATM and cancer risk group (4-5 December 2019).Fam Cancer. 2022 Apr;21(2):211-227. doi: 10.1007/s10689-021-00248-y. Epub 2021 Jun 14. Fam Cancer. 2022. PMID: 34125377 Free PMC article. Review.
-
Growth in ataxia telangiectasia.Orphanet J Rare Dis. 2021 Mar 10;16(1):123. doi: 10.1186/s13023-021-01716-5. Orphanet J Rare Dis. 2021. PMID: 33691726 Free PMC article.
-
Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancer.Br J Cancer. 1999 Aug;80(12):1979-81. doi: 10.1038/sj.bjc.6690630. Br J Cancer. 1999. PMID: 10471049 Free PMC article.
-
The pathogenesis of ataxia-telangiectasia. Learning from a Rosetta Stone.Clin Rev Allergy Immunol. 2001 Feb;20(1):87-108. doi: 10.1385/CRIAI:20:1:87. Clin Rev Allergy Immunol. 2001. PMID: 11269230 Review. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous